HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease.

AbstractBACKGROUND:
The radiographic changes of Mycobacterium avium complex (MAC) pulmonary disease during therapy have not been studied well.
OBJECTIVE:
To assess the efficacy of antituberculous drug therapy against MAC pulmonary disease using computed tomography (CT).
METHOD:
We analyzed chest CT scans before and after antituberculous therapy in 30 patients (21 women, 9 men) with MAC pulmonary disease. To evaluate radiographic changes during therapy, we defined a 'degree of improvement' (DI) that is calculated according to the CT appearance.
RESULTS:
DI was better (1.35 +/- 0.21) in patients who had converted sputum culture than in those who had not (0.44 +/- 0.25) (p < 0.05). In patients who were diagnosed by bronchial washing, DI was better (1.60 +/- 0.22) than in patients who were diagnosed by sputum (0.67 +/- 0.20) (p < 0.01). We categorized the CT appearance into 6 types: small nodules, cavities, bronchial wall thickening, infiltration, pleural thickening and atelectasis. Patients who showed pleural thickening had a significantly worse DI (0.12 +/- 0.40) than those who did not (1.23 +/- 0.18) (p < 0.01). Most of the lesions that disappeared after therapy were small nodules.
CONCLUSION:
These results indicate that chest CT might be a useful tool for the prediction or assessment of drug therapy for MAC pulmonary disease.
AuthorsSatoru Fujiuchi, Hiroyuki Matsumoto, Yasuhiro Yamazaki, Shoko Nakao, Masaaki Takahashi, Kazue Satoh, Akinori Takeda, Kiyotaka Okamoto, Yuka Fujita, Toshiaki Fujikane, Tetsuo Shimizu
JournalRespiration; international review of thoracic diseases (Respiration) 2003 Jan-Feb Vol. 70 Issue 1 Pg. 76-81 ISSN: 0025-7931 [Print] Switzerland
PMID12584395 (Publication Type: Journal Article)
CopyrightCopyright 2003 S. Karger AG, Basel
Chemical References
  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Ethambutol
  • Clarithromycin
  • Rifampin
  • Streptomycin
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Antitubercular Agents (therapeutic use)
  • Clarithromycin (therapeutic use)
  • Ethambutol (therapeutic use)
  • Female
  • Humans
  • Logistic Models
  • Lung Diseases (diagnostic imaging, drug therapy, microbiology)
  • Male
  • Middle Aged
  • Mycobacterium avium Complex
  • Mycobacterium avium-intracellulare Infection (diagnostic imaging, drug therapy)
  • Predictive Value of Tests
  • Rifampin (therapeutic use)
  • Streptomycin (therapeutic use)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: